McMeekin, Peter
Flynn, Darren
Allen, Mike
Coughlan, Diarmuid
Ford, Gary A.
Lumley, Hannah
Balami, Joyce S.
James, Martin A.
Stein, Ken
Burgess, David
White, Phil http://orcid.org/0000-0001-6007-6013
Funding for this research was provided by:
Programme Grants for Applied Research (RP-PG-1211-20012)
Article History
Received: 12 July 2019
Accepted: 25 October 2019
First Online: 8 November 2019
Ethics approval and consent to participate
: Not applicable
: Not Applicable
: This paper summarises independent research funded by the NIHR under its Programme Grant for Applied Research Programme (RP-PG-1211-20012). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. PW is co-PI for 2 randomised thrombectomy trials (PISTE & STABILISE) in acute stroke. Start-up phase of PISTE was mainly funded by the Stroke Association but was also part-funded by unrestricted educational grants from Covidien (now Medtronic) & Codman who manufacture stroke thrombectomy devices. STABILISE is part-funded by Microvention grant to Newcastle University. PW has undertaken consultancy work for Stryker, Codman & Microvention who manufacture stroke thrombectomy devices. GAF’s previous institution has received research grants from Boehringer Ingelheim (manufacturer of Alteplase), and honoraria from Lundbeck for stroke related activities. GAF has also received personal remuneration for educational and advisory work from Boehringer Ingelheim and Lundbeck. MAJ has received honoraria and support for educational activities from Boehringer Ingelheim and Medtronic.